High-Intensity Focused Ultrasound treatment, popularly known as HIFU, is fast becoming a game-changer in the management of tumours, prostate cancer and enlargement, as well as other conditions ...

High-intensity focused ultrasound (HIFU) is a noninvasive way to destroy tissue or stop it from working. It was approved by the U.S. Food and Drug Administration for prostate ablation in 2015, but the ...

Abstract: "HIFU beam" is a freely available software tool that comprises a MATLAB toolbox combined with a user-friendly interface and binary executable compiled from ...

The Focal One high-intensity focused ultrasound (HIFU) system. [Image courtesy of EDAP] EDAP TMS SA (Nasdaq:EDAP) announced today that the FDA granted 510(k) clearance for new workflows for its ...

High-Intensity Focused Ultrasound (HIFU), a non-invasive treatment for fibroids and adenomyosis, has recorded remarkable success in Nigeria. However, specialists warn that without government ...

根据贝哲斯咨询调研数据，2025年全球高强度聚焦超声（HIFU）市场规模达1.56亿元（人民币），中国高强度聚焦超声（HIFU）市场规模达0.46亿元。报告预测至2032年，全球高强度聚焦超声（HIFU）市场规模将会达到4.49亿元，预测期间内将以16.3%的年均复合增长率增长。

As a beauty journalist, I’m always curious about the latest skincare treatments. And while I’ve dabbled in injectables, I’m especially interested in treatments that work with your skin, encouraging ...

Khronos OpenVX is an open, royalty-free standard API for cross platform acceleration of computer vision applications. OpenVX enables performance and power-optimized computer vision functionality, ...

Urologic cancer surgeon Dr. Behfar Ehdaie said the new treatment approach "is safe and effective to treat specific areas and greatly reduce the burden on patients.” For people with prostate cancer ...

A high intensity focused ultrasound facial, or HIFU facial, is a noninvasive treatment for facial aging. This procedure is an anti-aging treatment that may provide some of the benefits of a facelift ...

Record full-year 2024 HIFU revenue of USD 25.7 million, an increase of 15.3% over full-year 2023 Record Q4 2024 HIFU revenue of USD 9.3 million, an increase of 15.0% over Q4 2023 U.S. Focal One HIFU ...

Men with intermediate-risk prostate cancer and high PSA levels before HIFU treatment had a greater risk of both overall recurrence and treatment failure. Men with intermediate-risk prostate cancer and ...